ascopubs.org

Real-world effectiveness and safety of first-line serplulimab in patients with metastatic or locally advanced esophageal carcinoma.

A retrospective study of characteristics and outcome of immune checkpoint inhibitor renal toxicities in a pan-cancer cohort of patients. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
Healio

Sacituzumab govitecan combo may be ‘new first-line standard of care’ in breast cancer subset

Please provide your email address to receive an email when new articles are posted on . Survival outcomes with the sacituzumab govitecan combination outweighed outcomes with chemotherapy combination ...
Healio

First-line combination should be ‘new standard’ in advanced lung cancer

Please provide your email address to receive an email when new articles are posted on . Amivantamab-vmjw plus lazertinib significantly improved OS for certain patients with advanced NSCLC compared ...